Mannatech Announces Intent to Commence a Cash Tender Offer to Purchase up to 211,538 Shares of Its Common Stock at a Purchase...
May 27 2021 - 10:09PM
Business Wire
Mannatech, Incorporated ("Mannatech" or the "Company")
(NASDAQ: MTEX), a global health and wellness company committed to
transforming lives to make a better world, intends to conduct a
cash tender offer to purchase up to 211,538 shares of its
outstanding common stock, par value $0.0001 per share, at a
purchase price of $26.00 per share.
The Company anticipates that Georgeson Securities Corporation
will be the dealer manager for the tender offer, Georgeson LLC will
serve as the information agent for the tender offer, and
Computershare Trust Company, N.A. will serve as the depositary for
the tender offer.
Important Additional Information
This communication is for informational purposes only, is not
a recommendation to buy or sell the Company’s common stock, and
does not constitute an offer to buy or the solicitation to sell
shares of the Company’s common stock. The tender offer described in
this communication has not yet commenced, and there can be no
assurances that the Company will commence the tender offer on the
terms described in this communication or at all. The tender offer
will be made only pursuant to the tender offer statement on
Schedule TO, including an Offer to Purchase, Letter of Transmittal
and related materials that the Company expects to file with the
Securities and Exchange Commission (“SEC”) upon commencement of the
tender offer.
SHAREHOLDERS AND HOLDERS OF AWARDS GRANTED UNDER THE
COMPANY'S EQUITY INCENTIVE PLANS ARE URGED TO CAREFULLY READ THE
TENDER OFFER STATEMENT, THE OFFER TO PURCHASE, LETTER OF
TRANSMITTAL AND RELATED MATERIALS WHEN THEY BECOME AVAILABLE
BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION, INCLUDING THE
VARIOUS TERMS OF, AND CONDITIONS TO, THE TENDER OFFER, THAT
SHAREHOLDERS AND AWARD HOLDERS SHOULD CONSIDER BEFORE MAKING ANY
DECISION REGARDING TENDERING THEIR SHARES.
Once the tender offer is commenced, shareholders will be able
to obtain a free copy of the tender offer statement on Schedule TO,
the Offer to Purchase, Letter of Transmittal and other related
documents that the Company will be filing with the SEC at the SEC’s
website at www.sec.gov. Additional copies of these materials may be
obtained for free by contacting the Company at ir@mannatech.com or
1410 Lakeside Pkwy, Ste 200, Flower Mound, TX 75028, Attn: Investor
Relations, or Georgeson LLC, the information agent for the tender
offer, at (877) 278-4751.
Other Disclosures
None of the Company, its directors, the dealer manager, the
information agent or the depositary for the tender offer will make
any recommendation to the shareholders as to whether to tender
their shares or refrain from tendering their shares.
About Mannatech
Mannatech, Incorporated is committed to transforming lives
through the development, marketing, and sales of high-quality,
proprietary nutritional supplements, topical and skin care and
anti-aging products, and weight-management products distributed
through its global network of independent associates and members.
The company has been operating for more than 25 years with
operations in 25 markets^. For more information, visit
Mannatech.com.
^ Mannatech operates in China under a cross-border e-commerce
platform that is separate from its network marketing model.
Please Note: This release contains “forward-looking statements.”
These forward-looking statements generally can be identified by use
of phrases or terminology such as “may,” “will,” “should,” "hope,"
“could,” “would,” “expects,” “plans,” “intends,” “anticipates,”
“believes,” “estimates,” “approximates,” “predicts,” “projects,”
“potential,” and “continues” or other similar words or the negative
of such terminology. Similarly, descriptions of Mannatech’s
objectives, strategies, plans, goals or targets contained herein
are also considered forward-looking statements. Mannatech believes
this release should be read in conjunction with all of its filings
with the SEC and cautions its readers that these forward-looking
statements are subject to certain events, risks, uncertainties, and
other factors. Some of these factors include, among others,
Mannatech's ability to complete the anticipated tender offer in a
timely manner or at all, the price at which shares of the Company's
common stock may trade on Nasdaq, which may be higher or lower than
the purchase price in the anticipated tender offer, uncertainty as
to the number of shares purchased in the tender offer, the impact
of the outbreak of the novel coronavirus ("COVID-19") pandemic,
Mannatech’s inability to attract and retain associates and members,
increases in competition, litigation, regulatory changes, and its
planned growth into new international markets. Although Mannatech
believes that the expectations, statements, and assumptions
reflected in these forward-looking statements are reasonable, it
cautions readers to always consider all of the risk factors and any
other cautionary statements carefully in evaluating each
forward-looking statement in this release, as well as those set
forth in its latest Annual Report on Form 10-K and Quarterly Report
on Form 10-Q, and other filings filed with the SEC, including its
current reports on Form 8-K. All of the forward-looking statements
contained herein speak only as of the date of this release.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210527005960/en/
Mannatech, Incorporated Donna Giordano, 972-471-7849 Manager,
Executive Office Administration ir@mannatech.com
www.mannatech.com
Mannatech (NASDAQ:MTEX)
Historical Stock Chart
From Jul 2024 to Aug 2024
Mannatech (NASDAQ:MTEX)
Historical Stock Chart
From Aug 2023 to Aug 2024